SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001048477-23-000070
Filing Date
2023-12-28
Accepted
2023-12-28 13:11:28
Documents
3
Period of Report
2023-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1703787078.html 3  
1 FORM 3 wk-form3_1703787078.xml 3 1602
2 EX-24 section16filingspowerofa.htm EX-24 4064
3 section16filingspowerofa001.jpg GRAPHIC 238517
  Complete submission text file 0001048477-23-000070.txt   335713
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Enyedy Mark J (Reporting) CIK: 0001586965 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26727 | Film No.: 231521390